Effective June 19, 2013, Dr. Thomas Spector resigned as Chief Scientific Officer of Adherex Technologies Inc., and entered into a Separation and Mutual Release Agreement with the company.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.67 USD | +1.99% |
|
+13.14% | -40.91% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.91% | 179M | |
+20.31% | 127B | |
+24.41% | 117B | |
+25.44% | 27.67B | |
-18.11% | 20.33B | |
-15.17% | 16.79B | |
-14.78% | 15.63B | |
+12.66% | 14.84B | |
-47.10% | 14.65B | |
+56.14% | 14.43B |
- Stock Market
- Equities
- FENC Stock
- News Fennec Pharmaceuticals Inc.
- Thomas Spector Resigns as Chief Scientific Officer of Adherex Technologies Inc